Application of the Stratified Cancer Surveillance Criteria to the Michigan Urologic Sugery Improvement Collaborative Active Surveillance Cohort: A Step Towards Risk Stratified Active Surveillance
Document Type
Conference Proceeding
Publication Date
5-2024
Publication Title
Journal of Urology
Abstract
INTRODUCTION AND OBJECTIVE: The STRATified CANcer Surveillance (STRATCANS) criteria were developed to risk stratify patients on active surveillance (AS) and prospectively tailor the intensity of surveillance testing according to their risk of biopsy upgrading. We tested applicability of the STRATCANS criteria to a diverse AS population, the Michigan Urologic Surgery Improvement Collaborative Active Surveillance (MUSIC) AS cohort. METHODS: We reviewed the MUSIC AS cohort for men diagnosed with Cambridge Prognostic Group (CPG) 1 (GG1 and PSA <10ng/mL and cT stage 1-2) and CPG 2 (GG1 and PSA 10-20 ng/mL and cT Stage 1-2 or GG2 and PSA
Volume
211
Issue
5S
First Page
e545
Last Page
e546
Recommended Citation
Wang M, Vercnocke JR, Diagnault-Newton S, Labardee C, Semierjian A, Borza T, et al. [Ginsburg K]. Application of the stratified cancer surveillance criteria to the Michigan Urologic Surgery Improvement Collaborative Active Surveillance Cohort: a stop towards risk stratified active surveillance. J Urol. 2024 May;211(5S):e545-e546. doi:10.1097/01.JU.0001008556.20565.76.05
DOI
10.1097/01.JU.0001008556.20565.76.05
Comments
American Urological Association Annual Meeting, May 3-6, 2024, San Antonio, TX